Although MAD1 has been found to play a role in chemotherapy resistance in CRC and ovarian cancer 52, 58, its effect on multidrug resistance in cancer chemotherapy has rarely been reported. This evidence concerns the gene MAD1L1 and ovarian carcinoma.